FDA issued a Warning Letter to Attix Pharmaceuticals on 6/22/2015 as a result of this inspection.
483 Attix Pharmaceuticals Nov 2014

483 Attix Pharmaceuticals Nov 2014

Christopher Middendorf FDA$119.00 - Available Now

FDA investigators audited the Attix Pharmaceuticals - Toronto, Canada facility and issued inspectional observations (via FDA 483) on 14 Nov 2014.

Product details

  • Category: Human Drugs
  • Inspection end: 14 Nov 2014
  • Location: Toronto, Canada
  • FEI: 3008197162
Add To Cart